Skip to main content
Premium Trial:

Request an Annual Quote

Turku Centre for Biotechnology Purchases Helicos Sequencer

Premium

Helicos BioSciences said this week that it has sold a Helicos Genetic Analysis System to the Turku Centre for Biotechnology in Finland, a joint facility of the University of Turku and Åbo Akademi University.

According to Helicos, this is the 10th sale of a HeliScope single-molecule sequencer. As of now, 12 Helicos sequencers are operating at customer sites, and another system, the sale of which the company previously announced, is "waiting for site preparations to be completed."

Helicos said last November that it had sold a sequencing system to a group of Dutch medical institutes, led by the Leiden University Medical Center (see In Sequence 11/17/2009).

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.